Manuel Nava

11PUBLICATIONS
37CO-AUTHORS
Respiratory diseasesHaematological tumoursPredictive and prognostic markersToxicology (incl. clinical toxicology)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 29, 2025
Immunology of Hypertension: Pathophysiological and Therapeutic Aspects.

Alexander Manzano, Heliana Parra, Daniela Ariza

|Aug 14, 2025
Neuroprotective Role of Omega-3 Fatty Acids: Fighting Alzheimer's Disease.

Mervin Chávez-Castillo, María Paula Gotera, Pablo Duran

|Feb 24, 2024
Pancreatic and Hepatic Injury in COVID-19: A Worse Prognosis in NAFLD Patients?

Edgardo Mengual-Moreno, Manuel Nava, Alexander Manzano

|Jan 08, 2023
Etelcalcetide and Paricalcitol in Chronic Kidney Disease: When the Target Is Inflammation.

Luis D'Marco, Ana Checa-Ros, Dionilux Gamero

|Mar 25, 2022
Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis.

Juan Salazar, Daniela Pirela, Manuel Nava

|Nov 18, 2021
SGLT2i and GLP-1RA in Cardiometabolic and Renal Diseases: From Glycemic Control to Adipose Tissue Inflammation and Senescence.

Luis D'Marco, Valery Morillo, José Luis Gorriz

Pageof 2